Prospective Multicenter Observational Study of Esophageal Preservation Survival in definitive Chemoradiotherapy +/- Photodynamic Therapy for Esophageal Cancer
- Conditions
- Esophageal Cancer
- Registration Number
- JPRN-UMIN000043767
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 150
Not provided
1) Women who are pregnant, may become pregnant (intentionally), or are breastfeeding. Men who wish their partner to become pregnant. 2) Patients with concomitant psychosis or psychiatric symptoms that would make it difficult to participate in the study. 3) Patients with active bacterial and fungal infections (fever of 38 degrees or higher, and bacterial infection documented by imaging or bacteriological examination. (Local infections that do not affect the systemic condition are excluded. 4) Patients with interstitial pneumonia, pulmonary fibrosis, or severe emphysema. 5) History of myocardial infarction or unstable angina within 6 months of enrollment. 6) Patients with poorly controlled valvular disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy. 7) Other patients who are judged by the physician in charge to be unable to tolerate the treatment prescribed in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year esophageal preservation survival, 5-year esophageal preservation survival of I-IVa esophageal cancer radical (chemo)radiation therapy plus salvage PDT
- Secondary Outcome Measures
Name Time Method